Skip to main content

Advertisement

Log in

Translation and psychometric evaluation of the Greek short forms of two condition-specific quality of life questionnaires for women with pelvic floor disorders: PFDI-20 and PFIQ-7

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Introduction and hypothesis

The aim of this study was the cross-cultural adaptation, validation, and psychometric evaluation in the Greek language of two self-reported instruments used for patients with pelvic floor disorders (PFDs): the Pelvic Floor Distress Inventory (PFDI-20) and the Pelvic Floor Impact Questionnaire (PFIQ-7).

Methods

For the cross-cultural adaptation, a multistep forward–back translation protocol was utilized. Evaluation of the psychometric properties of the questionnaires involved the assessment of validity, stability, internal consistency, and responsiveness. Validity, stability, and internal consistency were evaluated in women presenting with PFDs (group A), whereas responsiveness was assessed in women undergoing pelvic floor surgery (group B).

Results

A total of 100 women presenting with PFDs were included in Group A. A near excellent content/face validity was confirmed as assessed by the missing values criterion (0–5 %). Stability, as assessed by the intraclass correlation coefficient, showed almost perfect agreement with a mean ICC of 0.850 (PFDI-20) and 0.840 (PFIQ-7). Internal consistency was found to be high for both questionnaires (Cronbach’s alpha > 0.8). Finally, 85 women underwent pelvic floor repair surgery and were included for the assessment of responsiveness (group B). Good to excellent responsiveness was found for the prolapse and urinary subscales of the questionnaires. However, poor responsiveness was found for the colorectal–anal scale of the PFDI-20, whereas the colorectal–anal scale of the PFIQ-7 proved to be nonresponsive to change.

Conclusions

The Greek versions of PFDI-20 and PFIQ-7 were found to be comprehensible, valid, reliable, and responsive to use with patients complaining of PFDs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

PFDI:

Pelvic Floor Distress Inventory-20

POPDI:

Pelvic Organ Prolapse Distress Inventory-6

CRADI:

Colorectal–Anal Distress Inventory-8

UDI:

Urinary Distress Inventory-6

PFIQ:

Pelvic Floor Impact Questionnaire-7

UIQ:

Urinary Impact Questionnaire-7

CRAIQ:

Colorectal-Anal Impact Questionnaire-7

POPIQ:

Pelvic Organ Prolapse Impact Questionnaire-7

ES:

Effect sizes

SRM:

Standardized response mean

SD:

Standard deviation

ICC:

Intraclass correlation coefficient

CI:

Confidence interval

POPQ:

Pelvic organ prolapse quantification system

MCID:

Minimal clinically important difference

POP:

Pelvic organ prolapse

References

  1. Bump RC, Norton PA (1998) Epidemiology and natural history of pelvic floor dysfunction. Obstet Gynecol Clin North Am 25:723–746

    Article  PubMed  CAS  Google Scholar 

  2. Naughton MJ, Donovan J, Badia X, Corcos J, Gotoh M, Kelleher C, Lukacs B, Shaw C (2004) Symptom severity and QOL scales for urinary incontinence. Gastroenterology 126:S114–S123

    Article  PubMed  Google Scholar 

  3. Barber MD, Walters MD, Cundiff GW, PESSRI Trial Group (2006) Responsiveness of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ) in women undergoing vaginal surgery and pessary treatment for pelvic organ prolapse. Am J Obstet Gynecol 194(5):1492–1498

    Article  PubMed  Google Scholar 

  4. Barber MD, Kuchibhatla MN, Pieper CF, Bump RC (2001) Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. Am J Obstet Gynecol 185(6):1388–1395

    Article  PubMed  CAS  Google Scholar 

  5. Barber MD, Walters MD, Bump RC (2005) Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol 193(1):103–113

    Article  PubMed  CAS  Google Scholar 

  6. De Tayrac R, Deval B, Fernandez H, Marès et P, Mapi Research Institute (2007) Development of a linguistically validated French version of two short-form, condition-specific quality of life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). J Gynecol Obstet Biol Reprod (Paris) 36(8):738–748

    Article  CAS  Google Scholar 

  7. Teleman P, Stenzelius K, Iorizzo L, Jakobsson U (2011) Validation of the Swedish short forms of the Pelvic Floor Impact Questionnaire (PFIQ-7), Pelvic Floor Distress Inventory (PFDI-20) and Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12). Acta Obstet Gynecol Scand 90(5):483–487

    Article  PubMed  Google Scholar 

  8. Kaplan PB, Sut N, Sut HK (2012) Validation, cultural adaptation and responsiveness of two pelvic-floor-specific quality-of-life questionnaires, PFDI-20 and PFIQ-7, in a Turkish population. Eur J Obstet Gynecol Reprod Biol 162(2):229–233

    Article  PubMed  Google Scholar 

  9. Guillemin F, Bombardier C, Beaton D (1993) Cross-cultural adaptation of Health-Related Quality of Life measures: literature review and proposed guidelines. J Clin Epidemiol 46:1417–1432

    Article  PubMed  CAS  Google Scholar 

  10. Beaton DE, Bombardier C, Guillemin F, Ferraz MB (2000) Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 25:3186–3191

    Article  PubMed  CAS  Google Scholar 

  11. Streiner DL, Norman GR (2003) Health measurement scales: a practical guide to their development and use, 3rd edn. Oxford University Press, Oxford (UK)

    Google Scholar 

  12. Guyatt GH, Feeny DH, Patrick DL (1993) Measuring health-related quality of life. Ann Intern Med 118:622–629

    Article  PubMed  CAS  Google Scholar 

  13. Fitzpatrick R, Davey C, Buxton MJ, Jones DR (1998) Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess 2(14):i–iv, 1–74

    Google Scholar 

  14. Portney LG, Watkins MP (1993) Foundations of clinical research: applications to practice. McGraw-Hill/Appleton and Lange, Norwalk

    Google Scholar 

  15. Sushil S, Verma N (2010) Questionnaire validation made easy. Eur J Sci Res 46(2):172–178

    Google Scholar 

  16. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B et al (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21:5–26. doi:10.1007/s00192-009-0976-9

    Article  PubMed  Google Scholar 

  17. Kazis LE, Anderson JJ, Meenan RF (1989) Effect sizes for interpreting changes in health status. Med Care 27:178–189

    Article  Google Scholar 

  18. Deyo RA, Diehr P, Patrick DL (1991) Reproducibility and responsiveness of health status measures: statistics and strategies for evaluation. Control Clin Trials 12:42–158

    Article  Google Scholar 

  19. Crosby RD, Kolotkin RL, Rhys WG (2003) Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol 56:395–407

    Article  PubMed  Google Scholar 

  20. Draft Guidance for Industry (2006) Patient-reported outcomes measures: use in medical product development to support labeling claims. Docket 2006D-0044, MD: FDA Federal Register, Rockville

  21. Acquadro C, Conway K, Hareendran A, Aaronson N, European Regulatory Issues and Quality of Life Assessment (ERIQA) Group (2008) Literature review of methods to translate health-related quality of life questionnaires for use in multinational clinical trials. Value Health 11(3):509–521

    Article  PubMed  Google Scholar 

  22. Toprak Celenay S, Akbayrak T, Kaya S, Ekici G, Beksac S (2012) Validity and reliability of the Turkish version of the Pelvic Floor Distress Inventory-20. Int Urogynecol J 23(8):1123–1127

    Article  PubMed  Google Scholar 

  23. Enck P, Bielefeldt K, Rathmann W, Purrmann J, Tschöpe D, Erckenbrecht JF (1991) Epidemiology of faecal incontinence in selected patient groups. Int J Colorectal Dis 6:143–146

    Article  PubMed  CAS  Google Scholar 

  24. Young AE, Fine PM, McCrery R, Wren PA, Richter HE, Brubaker L, Brown MB, Weber AM, Network PFD (2007) Spanish language translation of pelvic floor disorders instruments. Int Urogynecol J 18:1171–1178

    Article  Google Scholar 

  25. El-Azab AS, Mascha EJ (2009) Arabic validation of the Urogenital Distress Inventory and Adapted Incontinence Impact Questionnaires—short forms. Neurourol Urodyn 28:33–39

    Article  PubMed  Google Scholar 

  26. Weber AM, Walters MD, Ballard LA, Booher DL, Piedmonte MR (1998) Posterior vaginal wall prolapse and bowel function. Am J Obstet Gynecol 179:1446–1450

    Article  PubMed  CAS  Google Scholar 

  27. Burrows LJ, Meyn LA, Walters MD, Weber AM (2004) Pelvic symptoms in women with pelvic organ prolapse. Obstet Gynecol 104:982–988

    Article  PubMed  Google Scholar 

  28. Kahn MA, Breitkopf CR, Valley MT, Woodman PJ, O’Boyle AL, Bland DI et al (2005) Pelvic organ support study and bowel symptoms: straining at stool is associated with perineal and anterior vaginal descent in a general gynecologic population. Am J Obstet Gynecol 192:1516–1522

    Article  PubMed  Google Scholar 

  29. Marques da Silva G, Gurland B, Sleemi A, Levy G (2006) Posterior vaginal wall prolapse does not correlate with fecal symptoms or objective measures of anorectal function. Am J Obstet Gynecol 195:1742–1747

    Article  Google Scholar 

Download references

Conflict of interest

None.

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Themos Grigoriadis.

Appendices

Appendix 1 (Greek questionnaires)

figure afigure afigure afigure afigure afigure a

Appendix 2

Observed stability of each question of the PFDI-20 and PFIQ-7 questionnaires evaluated using the intraclass correlation coefficient (ICC)

 

Stability: ICC (95 % CI)

p value*

PFDI-20 (n = 100)

0.850 (0.785–0.896)

<0.001**

  POPDI-6

0.870 (0.813–0.911)

<0.001**

 

POPDI-6/q1

0.690 (0.572–0.780)

POPDI-6/q2

0.740 (0.637–0.817)

POPDI-6/q3

0.920 (0.884–0.945)

POPDI-6/q4

0.740 (0.637–0.817)

POPDI-6/q5

0.680 (0.559–0.773)

POPDI-6/q6

0.850 (0.785–0.896)

  CRADI-8

0.750 (0.650–0.824)

<0.001**

 

CRADI-8/q1

0.650 (0.521–0.750)

CRADI-8/q2

0.660 (0.534–0.757)

CRADI-8/q3

0.740 (0.637–0.817)

CRADI-8/q4

0.730 (0.624–0.810)

CRADI-8/q5

0.800 (0.717–0.861)

CRADI-8/q6

0.630 (0.496–0.735)

CRADI-8/q7

0.590 (0.446–0.704)

CRADI-8/q8

0.330 (0.144–0.493)

  UDI-6

0.780 (0.690–0.846)

<0.001**

 

UDI-6/q1

0.810 (0.730–0.868)

UDI-6/q2

0.780 (0.690–0.846)

UDI-6/q3

0.820 (0.744–0.875)

UDI-6/q4

0.830 (0.758–0.882)

UDI-6/q5

0.710 (0.598–0.795)

UDI-6/q6

0.670 (0.546–0.765)

PFIQ-7 (n = 100)

0.840 (0.771–0.890)

<0.001**

  UIQ-7

0.830 (0.758–0.882)

<0.001**

 

UIQ-7/q1

0.740 (0.637–0.817)

UIQ-7/q2

0.740 (0.637–0.817)

UIQ-7/q3

0.690 (0.572–0.780)

UIQ-7/q4

0.730 (0.624–0.810)

UIQ-7/q5

0.660 (0.534–0.757)

UIQ-7/q6

0.720 (0.611–0.802)

UIQ-7/q7

0.710 (0.594–0.797)

  CRAIQ-7

0.697 (0.584–0.787)

<0.001**

 

CRAIQ-7/q1

0.640 (0.508–0.742)

CRAIQ-7/q2

0.730 (0.624–0.810)

CRAIQ-7/q3

0.620 (0.483–0.727)

CRAIQ-7/q4

0.650 (0.526–0.765)

CRAIQ-7/q5

0.630 (0.496–0.735)

CRAIQ-7/q6

0.520 (0.362–0.649)

CRAIQ-7/q7

0.650 (0.524–0.766)

  POPIQ-7

0.770 (0.677–0.839)

<0.001**

 

POPIQ-7/q1

0.730 (0.624–0.810)

POPIQ-7/q2

0.690 (0.572–0.780)

POPIQ-7/q3

0.700 (0.585–0.787)

POPIQ-7q4

0.660 (0.534–0.757)

POPIQ-7/q5

0.730 (0.624–0.810)

POPIQ-7/q6

0.690 (0.572–0.780)

POPIQ-7/q7

0.660 (0.532–0.759)

  1. PFDI Pelvic Floor Distress Inventory, POPDI Pelvic Organ Prolapse Distress Inventory, CRADI Colorectal–Anal Distress Inventory, UDI Urinary Distress Inventory, PFIQ Pelvic Floor Impact Questionnaire, UIQ Urinary Impact Questionnaire, CRAIQ Colorectal–Anal Impact Questionnaire, POPIQ Pelvic Organ Prolapse Impact Questionnaire, CI coefficient interval
  2. *ANOVA method
  3. **Statistically significant

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grigoriadis, T., Athanasiou, S., Giannoulis, G. et al. Translation and psychometric evaluation of the Greek short forms of two condition-specific quality of life questionnaires for women with pelvic floor disorders: PFDI-20 and PFIQ-7. Int Urogynecol J 24, 2131–2144 (2013). https://doi.org/10.1007/s00192-013-2144-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-013-2144-5

Keywords

Navigation